PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsZimberelimab
Zimberelimab
Zimberelimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
70 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD002289——241——7
Lung neoplasmsD008175—C34.90141——6
AdenocarcinomaD000230———11——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C80102———11
CarcinomaD002277—C80.0—3———3
Squamous cell carcinoma of head and neckD000077195———2———2
Squamous cell carcinomaD002294———2———2
Colorectal neoplasmsD015179——11———1
Prostatic neoplasmsD011471—C6111———1
Castration-resistant prostatic neoplasmsD064129——11———1
Gastrointestinal diseasesD005767———1———1
Bile duct neoplasmsD001650———1———1
CholangiocarcinomaD018281—C22.1—1———1
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C161————1
Esophageal neoplasmsD004938—C151————1
Non-hodgkin lymphomaD008228—C85.91————1
Multiple myelomaD009101—C90.01————1
LymphomaD008223—C85.91————1
MelanomaD008545——1————1
Uterine cervical neoplasmsD002583——1————1
Large b-cell lymphoma diffuseD016403—C83.31————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameZimberelimab
INNzimberelimab
Description
Zimberelimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL4297856
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDZBL7O904IL (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 411 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
203 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use